Primary Cutaneous Follicle Center Lymphoma in an Adult African American Male

Main Article Content

Amanda Arreola
Andraya Gower
Pamela Allen
Joshua Brady
Igor Shendrik


Cutaneous Lymphoma, Skin of Color, Primary Cutaneous Follicle Center Lymphoma


Primary cutaneous B-Cell Lymphomas (PCBCL) is a form of a lymphoproliferative neoplasm consisting of proliferation localized to the skin. Cutaneous lymphomas originate from mature T-lymphocytes, B-lymphocytes, or NK cells. The incidence of PCBCL is significantly lower in patients with Skin of Color (SoC) and is quite rare among African American (AA) individuals, compared to their Caucasian counterparts. The clinical course of PCFCL in SoC is not widely studied or reported in literature due to the low incidence in the AA population. We present a case of PCBCL in an AA individual along with a brief review of the clinical presentation, pathology, and treatment options of the condition.  According to the U.S. Census Bureau, approximately half of the U.S population will have SoC by 2050; by adding our case of PCFCL to the body of literature, we hope to promote awareness of the presentation and course of this cutaneous disorder in SoC patients. 


1. Bradford PT, Devesa SS, Anderson WF, Toro JR. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood. 2009;113(21):5064-5073. doi:10.1182/blood-2008-10-184168

2. Willemze R, Cerroni L, Kempf W, et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas [published correction appears in Blood. 2019 Sep 26;134(13):1112]. Blood. 2019;133(16):1703-1714. doi:10.1182/blood-2018-11-881268

3. Geller, S., Pulitzer, M., Myskowski, P.; Kheterpal, M. (2018, December 1). Low-Grade Cutaneous B-cell Lymphoma in African American Patients. Retrieved June 26, 2020, from

4. Hamilton SN, Wai ES, Tan K, Alexander C, Gascoyne RD, Connors JM. Treatment and outcomes in patients with primary cutaneous B-cell lymphoma: the BC Cancer Agency experience. Int J Radiat Oncol Biol Phys. 2013;87(4):719-725. doi:10.1016/j.ijrobp.2013.07.019

5. Lima M. Cutaneous primary B-cell lymphomas: from diagnosis to treatment. An Bras Dermatol. 2015;90(5):687-706. doi:10.1590/abd1806-4841.20153638

6. Perry A, Vincent BJ, Parker SR. Intralesional corticosteroid therapy for primary cutaneous B-cell lymphoma. Br J Dermatol. 2010 Jul;163(1) 223-225. doi:10.1111/j.1365-2133.2010.09798.x. PMID: 20394622.